Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Watch Out for the Most Promising Therapies in t...

Acute respiratory distress syndrome (ARDS) is a rapidly progressing condition that affects critically ill people. The major complication of ARDS is fluid leaking into the lungs, which makes breathi...

Aug 29, 2022

ards-market-outlook
What Factors are Shaping the Trends in the ARDS Market?

Despite decades of research, treatment options are limited in the ARDS market. There are only a few treatments available in the ARDS market. The mainstay of management remains supportive care with mechanical ventilation. Other ARDS treatment options for patients include supplemental oxygen, prone positioning, the u...

Find More
Applications and Benefits of Nanotechnology in Healthcare Market
Understanding How Emerging Applications of Nanotechnology are Upgrading the Healthcare Delivery?

Nanotechnology is an evolving and innovative technology set to transform healthcare dynamics to its core with promising applications. Advancements in nanoscience have led to the emergence of a new generation of nanostructures that are employable in the healthcare industry to a much larger extent. With the unique ab...

Find More
driving-factors-for-ards-prevalence
Rising Acute Respiratory Distress Syndrome (ARDS) Prevalence Posing a Major Public Health Concern

The acute respiratory distress syndrome (ARDS) prevalence is increasing every year; it is estimated that in the United States alone, about 190K Americans are diagnosed with ARDS each year. Prior to the COVID-19 global pandemic, more than 700K individuals in the US and 2 million cases globally developed ARDS from tr...

Find More

More Views & Analysis

aav-vectors-in-gene-therapy-landscape
AAV Vectors in Gene Therapy: How Recent Clinical Advances are Unraveling New Potentials?

There has been a renaissance in gene therapy attempts, spurred partly by the discovery and understanding of novel gene delivery vectors. Adeno-associated virus (AAV) is a non-enveloped virus that may be designed to carry DNA to target cells and has sparked considerable interest in the area, particularly in clinical...

Find More

congenital-adrenal-hyperplasia-treatment-landscape
Will The Emerging Pipeline Address The Congenital Adrenal Hyperplasia Treatment Puzzle?

Congenital adrenal hyperplasia (CAH) is a rare inherited autosomal recessive disorder defined by a lack of one of the enzymes required to produce specific hormones. In the United States and Europe, the most prevalent type of CAH, 21 hydroxylase deficiency, affects around 1:10,000 to 1:15,000 people. The estimated C...

Find More

emerging-molluscum-contagiosum-treatment
What to Expect for the Molluscum Contagiosum Treatment in the Coming Years?

Molluscum contagiosum, often known as water warts, is a common superficial skin disease caused by the poxvirus. The molluscum contagiosum virus (MCV) is one of the world's 50 most common diseases. It mostly affects school-aged children, sexually active young adults, and immunocompromised people.  As per our...

Find More

dystrophic-epidermolysis-bullosa-treatment-market
Which Pipeline Therapy Has The Potential To Revolutionize The Dystrophic Epidermolysis Bullosa Treatment Market?

Dystrophic epidermolysis bullosa (DEB) is a common skin disease with a chronic history and low healing rates. Despite current management therapies, the disease has the potential to become severe and devastating for many patients over time. Dystrophic epidermolysis bullosa is classified into six types: dominant dyst...

Find More

emerging-pml-treatment
New Approved PML Treatment Options – A Long-awaited Hope for PML Patients

Progressive multifocal leukoencephalopathy is a severe, progressive, and lethal demyelinating disease that presents in immunocompromised states. It is a rare indication, with just over 1.5K PML diagnosed incident cases in the United States, per DelveInsight analysis. It occurs in the setting of predisposing immunos...

Find More

generalized-myasthenia-gravis-treatment-market
Can FcRn Antagonists Be The Game-Changer in the Generalized Myasthenia Gravis (gMG) Treatment Market?

Though a rare disease, generalized myasthenia gravis (gMG) still affects around 60,000 people in the US and another 100,000 in EU-5 and Japan. As per our analysis, the total diagnosed prevalent cases of gMG were approx 116K in the 7MM in 2021. These numbers are further estimated to increase by 2032. Moreover, t...

Find More

The first biosimilar was made available to patients in the United States six years ago in 2021. Thes.....

Find More

The medical device industry is a dynamic, innovative, and heterogeneous sector. The MedTech industry.....

Find More

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Find More

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthrit.....

Find More

Diabetic retinopathy is an eye condition that leads to vision loss and blindness in people who have .....

Find More

Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....

Find More